WHO ICTRP trial

An intervention study on the effect of digital self-monitoring-based management…

NL-OMON54476 · Overview of Medical Research in the Netherlands (NL-OMON) · Recruiting

Key facts

Trial ID NL-OMON54476
Public title An intervention study on the effect of digital self-monitoring-based management of relapsing and remitting multiple sclerosis on self-efficacy, clinical outcomes and cost-effectiveness
Scientific title An intervention study on the effect of digital self-monitoring-based management of relapsing and remitting multiple sclerosis on self-efficacy, clinical outcomes and cost-effectiveness - Multiple sclerosis self-monitoring (MSSM)
Primary sponsor Vrije Universiteit Medisch Centrum
Registry Overview of Medical Research in the Netherlands (NL-OMON)
Recruitment status Recruiting
Study type Interventional
Countries Netherlands
Conditions MS Multiple sclerosis;10012303
Interventions One group receives the MS sherpa application (~6 min/week self monitoring through a questionnaire, walking test and cognition test) in addition to standard care and the other group receives standard care.
Registration date Jun 9, 2022
Target size 210
Secondary IDs NL75687.029.22
Registry page onderzoekmetmensen.nl

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations